APA (7th ed.) Citation

M, L., M, K., AM, H., IC, v. d. P., MJH, J., K, I., . . . T, V. (2026). Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. Blood neoplasia, 3(3), 100242. https://doi.org/10.1016/j.bneo.2026.100242

Chicago Style (17th ed.) Citation

M, Lustig, et al. "Myeloid Cell-mediated Killing of B-ALL by CD38 and CD20 IgA Antibody Variants Is Enhanced by CD47/SIRPα Interference." Blood Neoplasia 3, no. 3 (2026): 100242. https://doi.org/10.1016/j.bneo.2026.100242.

MLA (9th ed.) Citation

M, Lustig, et al. "Myeloid Cell-mediated Killing of B-ALL by CD38 and CD20 IgA Antibody Variants Is Enhanced by CD47/SIRPα Interference." Blood Neoplasia, vol. 3, no. 3, 2026, p. 100242, https://doi.org/10.1016/j.bneo.2026.100242.